Regulatory Affairs Training Course Calendar

Back to details

Training format

Topic

Our Regulatory Affairs calendar for the next 12 months:

Live online Classroom 2025 2026
Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov
A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products Regulatory Affairs 7 3
A Practical Approach to Veterinary Vaccine Development and Registration in the EU Regulatory Affairs 10-11 23-24
A Regulatory Update on the Medical Device and In-Vitro Diagnostic Regulations in the EU and UK Regulatory Affairs 29 20
Advanced Regulatory Affairs for Medical Devices Regulatory Affairs
An Essential Overview of Medical Information Regulatory Affairs 4 22
An Essential Overview of the Pharmaceutical and Biotech Industries Regulatory Affairs 12 28
An Introduction to Ethylene Oxide (EO) Sterilization for Medical Devices Regulatory Affairs 14 9
An Introduction to Human Factors for Pharmaceutical and Medical Device Professionals Regulatory Affairs 8 19
An Introduction to ISO 11607 - Packaging for Terminally Sterilized Medical Devices Regulatory Affairs
An Introduction to ISO 13485: 2016 - Quality Management System (QMS) for Medical Devices Regulatory Affairs 21 18
An Introduction to the Medical Device Regulation Regulatory Affairs
An introduction to Risk Management ISO 14971:2019 Regulatory Affairs 27 20
Animal Feed and Feed Additive Registration in China and Thailand Regulatory Affairs 16 22
Antimicrobial Resistance (AMR) and 'One Health': Current Challenges, Regulatory Frontiers and Future Solutions Regulatory Affairs 10 10
Best Practice for Writing Effective SOPs Regulatory Affairs 4 26 14 26
Biological Evaluation of Medical Devices Regulatory Affairs 21-22 13-14
CAPA (Corrective and Preventative Action) Regulatory Affairs 5 15
Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products Regulatory Affairs 23-24 19-20
Classification of Software as a Medical Device (SaMD) and Medical Device Software (MDSW) Regulatory Affairs
Cleanroom Requirements for Medical Device Manufacturers Regulatory Affairs 23 21
Clinical Overview and Clinical Summary: Creating Effective Marketing Authorisation Application Regulatory Affairs 16-17 30-1
Cyber Security for Medical Devices Regulatory Affairs 19-20 28-29
Data Innovation for AI-enabled Medical Devices Regulatory Affairs
Developing and Managing Software as a Medical Device (SaMD) and Medical Device Software (MDSW) Regulatory Affairs
EU Pharmaceutical Regulations & Strategy Regulatory Affairs 2-3 5-6
EU Proposed Pharmaceutical Legislation Changes Regulatory Affairs 19 1
FDA Approval Process for Medical Devices Regulatory Affairs 2-3 30-1
Global Market Access for Medical Device Software Regulatory Affairs 1-2 8-9 30-1
Human Factors and Usability Engineering in the Development of Drug Delivery Products Regulatory Affairs 11-12 15-16
ICH Q9(R1) Quality Risk Management (QRM) Regulatory Affairs
Introduction to the In-Vitro Diagnostic Regulation (IVDR) Regulatory Affairs 16-17 15-16
Market Authorisation of Software as a Medical Device (SaMD) and Medical Device Software (MDSW) Regulatory Affairs
Masterclass: Market Authorisation of AI-enabled Medical Devices Regulatory Affairs 19-20 17-18
Medical Device Regulation in the Eurasian Union, Russia and the CIS Regulatory Affairs 9-10 30-1
Medical Device Regulations in Asia-Pacific Markets Regulatory Affairs 3-4 16-17
Medical Device Regulations in the Middle East and North Africa Regulatory Affairs 18-19 18-19
Medical Device Single Audit Programme (MDSAP) Regulatory Affairs 25-26 25-26
Navigating EU and FDA Regulations for Drug/Device and Device/Drug Combination Products Regulatory Affairs 2-3 14-15
Navigating Regulatory Compliance Whilst Developing and Distributing Polymerase Chain Reaction (PCR)-Based IVD Tests Regulatory Affairs 15 9
Non-Conformance and Corrective Action for Medical Device Manufacturers Regulatory Affairs 11 19
Orphan Drug Regulatory Masterclass: EU & US Insights Regulatory Affairs 4 6
Pharmaceutical Regulatory Affairs in Africa Regulatory Affairs 6-7 3-4
Pharmaceutical Regulatory Affairs in Asia Regulatory Affairs 24-26 7-9
Pharmaceutical Regulatory Affairs in China Regulatory Affairs 12-13 25-26
Pharmaceutical Regulatory Affairs in Russia and the Eurasian Union Regulatory Affairs 5-6 30-1
Pharmaceutical Regulatory Affairs in the Middle East Regulatory Affairs 24-25 20-21
Pharmaceutical Regulatory Affairs in the Middle East and North Africa Regulatory Affairs
Registration of Veterinary Pharmaceuticals in China Regulatory Affairs 16 22
Regulatory Affairs for Support Staff Regulatory Affairs 11-12 21-22
Regulatory Compliance and Safety Standards for Aesthetic Devices Regulatory Affairs 5 12
Sterilization of Medical Devices Regulatory Affairs 23-24 15-16
The 2024 EU AI Act Regulatory Affairs 23
The Common Technical Document (CTD) Submission in the MENA Region Regulatory Affairs 19 27
The FDA Drug Approval Process Regulatory Affairs 23-24 24-25
The Regulatory Requirements on Nitrosamines in the Pharmaceutical Industry Regulatory Affairs 27-28 12-13
The Role of the Person Responsible for Regulatory Compliance (PRRC) Under the MDR and IVDR Regulatory Affairs 4 21
UK Conformity Assessed (UKCA) Marking for Medical Devices Regulatory Affairs 15 21
US FDA - Understanding Key Factors When Working with the FDA Regulatory Affairs 12 25
Understanding Active Pharmaceutical Ingredients (APIs) Regulatory Affairs 29-30 21-22
Understanding Computer System Validation (CSV) Regulatory Affairs 17-18
Unique Device Identification (UDI) and Labelling for Medical Device Manufacturers Regulatory Affairs 8 30
Variations to Marketing Authorisations Regulatory Affairs 2-3 11-12
Veterinary Pharmaceutical Submissions in the EU Regulatory Affairs 18-19 19-20